Responses
Immunotherapy biomarkers
Original research
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
